Imidazo-containing compounds (e.g., imidazoquinolines, imidazonaphthyridines, and imidazopyridines) with an oxime substituent at the 1-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Imidazo ring compounds (e.g., imidazoquinolines, 6,7,8,9-tetrahydroimidazoquinolines, imidazonaphthyridines, and imidazopyridines) with an oxime substituent at the 2-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Oxime and Hydroxylamine Substituted Thiazolo [4,5-C] Ring Compounds and Methods
申请人:Lundquist, JR. Gregory D.
公开号:US20100240693A1
公开(公告)日:2010-09-23
Thiazolo[
4,5
-c]ring compounds, (e.g. thiazolopyridine, thiazoloquinoline,
6,7,8,9
-tetrahydrothiazoloquinoline, thiazolonaphthyridine, and
6,7,8,9
-tetrahydrothiazolonaphthyridine compounds) having an oxime or hydroxylamine substituent at the
2
-position, pharmaceutical compositions containing the compounds, intermediates, and methods of making and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.